Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure. - Wikidata - awgldk - TriplyDB

Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure.

Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure.

http://www.wikidata.org/entity/Q33701409

about

Characterization of Neisseria gonorrhoeae strains with decreased susceptibility to fluoroquinolones isolated in Greece from 1996 to 1999.Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998 High prevalence of high-level ciprofloxacin resistance in Neisseria gonorrhoeae in Tel Aviv, Israel: correlation with response to therapy.Gonorrhoea in London: usefulness of first line therapies.Susceptibility of gonococci isolated in London to therapeutic antibiotics: establishment of a London surveillance programme. London Gonococcal Working Group Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae.Sex, sun, sea, and STIs: sexually transmitted infections acquired on holiday.Global fluoroquinolone resistance epidemiology and implictions for clinical use.

P2860

Q33969765-AA1723D3-4557-456F-9CE1-01BC047C1E19 Q33981137-D7042758-4F21-4D64-952D-0FD676AD8501 Q34108297-F530C00A-9D45-4D76-A29E-48B8699A7665 Q35529838-453E7D78-2882-4996-A290-C03BE3E92FCB Q35562459-16921AC4-C9C2-4658-9E47-BD2C6D321577 Q35562906-997738CC-5FCC-493D-8A48-0438EB65EBD2 Q35611039-D6757752-3380-4A01-B516-9825B09868DB Q35844641-BA089628-4752-44FE-8D23-258261808E0A Q36337074-2ED2570C-9144-417C-A2A1-BDFB1D6D8A9D

P2860

Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure.

http://www.wikidata.org/entity/Q33701409

description

1998 nî lūn-bûn

@nan

1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Drift in susceptibility of Nei ...... rgence of therapeutic failure.

@ast

Drift in susceptibility of Nei ...... rgence of therapeutic failure.

@en

type

label

Drift in susceptibility of Nei ...... rgence of therapeutic failure.

@ast

Drift in susceptibility of Nei ...... rgence of therapeutic failure.

@en

prefLabel

Drift in susceptibility of Nei ...... rgence of therapeutic failure.

@ast

Drift in susceptibility of Nei ...... rgence of therapeutic failure.

@en

P1433

Q33701409-521A597C-E5DB-4611-A430-A811C5C9DC49

P1476

Q33701409-BB94A8B9-E283-4118-AD84-F5A1821A694D

P2093

Q33701409-4E4BF1E3-7FAC-45A8-B8DB-A0FBE91201EA

Q33701409-77B6241A-48B5-4F10-B8D9-3851FC8BE446

Q33701409-9A0E2C66-601C-448F-9F62-D4F67906C9B4

Q33701409-B4F151EF-28D6-4B4B-B597-59A363F6FCA0

P2860

Q33701409-04D4A9EE-1E2D-412E-870A-ECE331E1FEDA

Q33701409-0B659854-E59B-4690-BBC2-D0204ACFC6B8

Q33701409-12C19757-2238-4868-9EA9-47EFBA86EDC4

Q33701409-179586DA-6D87-4B55-81C4-524D47BFE9A1

Q33701409-1CA7B835-F8D2-49FF-A3D0-4320B1B275A8

Q33701409-1F03A15D-BFE9-40BE-A305-1E303806A21A

Q33701409-25AA7A49-4887-4176-B371-444567F60F24

Q33701409-2C4001C0-E1C5-4A09-A95E-C5C09717D91A

Q33701409-2FBC53DC-DA64-4EB6-A6BB-375980EE84DD

Q33701409-3DED374D-B42F-4D81-B49E-89DFC01B1202

P304

Q33701409-BB1AF339-4372-48B3-899A-B4AC0C689787

P31

Q33701409-8718D7AA-BD0B-429F-9212-D823DE498E7F

P356

Q33701409-657C1792-6B43-4973-B972-AE758F57E0C3

P407

Q33701409-6394EB39-D054-41A3-B479-5210F8FF3D27

P433

Q33701409-3591BDD9-0B41-49AC-A0F6-6642428EF9F9

P478

Q33701409-32AFB91D-B5E8-4F74-9E5E-ABD1461BFEB8

P577

Q33701409-D02C7045-6B6B-4E80-AA79-EEFC6B8A3B04

P698

Q33701409-07928F14-1D1C-4EA0-8842-F06769073CA5

P921

Q33701409-0350FAF9-2723-42F5-A2A8-92CFCF386C06

P932

Q33701409-52CEF4DB-164D-4D00-A11C-A2AE41DF9B89

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Drift in susceptibility of Nei ...... ergence of therapeutic failure

@en

P2093

C A Ison

http://www.w3.org/2001/XMLSchema#string

E Claydon

http://www.w3.org/2001/XMLSchema#string

H Madders

http://www.w3.org/2001/XMLSchema#string

P J Woodford

http://www.w3.org/2001/XMLSchema#string

P2860

Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993

Emerging in vitro resistance to quinolones in penicillinase-producing Neisseria gonorrhoeae strains in Hawaii.

Associations between serotype and susceptibility to antibiotics of Neisseria gonorrhoeae.

Rapid decline in penicillinase-producing Neisseria gonorrhoeae in Hong Kong associated with emerging 4-fluoroquinolone resistance

Reduced clinical efficacy of pazufloxacin against gonorrhea due to high prevalence of quinolone-resistant isolates with the GyrA mutation. The Pazufloxacin STD Group.

DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae.

Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.

Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus.

Quinolone-resistant Neisseria gonorrhoeae isolated in Sydney, Australia, 1991 to 1995.

Molecular epidemiology, in 1994, of Neisseria gonorrhoeae in Manila and Cebu City, Republic of the Philippines.

P304

2919-2922

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.42.11.2919

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

1998-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9797226

http://www.w3.org/2001/XMLSchema#string

P921

Neisseria gonorrhoeae

P932

105966

http://www.w3.org/2001/XMLSchema#string